Search

everythinglearnresearchcommunity

for

Search:↓

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Combining Minoxidil and finasteride is more effective for hair growth but may cause side effects.

Finasteride is more harmful to male reproductive health than minoxidil.

Women with PCOS in Bangladesh face significant mental health issues, especially in rural areas.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Minoxidil lotion may harm male reproductive health.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

COVID-19 may harm male fertility and damage the reproductive system.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Probiotic bacteria improved skin and hair health in aged mice.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Finasteride is effective for hair loss and prostate issues but may cause lasting side effects.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Addressing personal and moral aspects can improve sexual satisfaction.